163
Participants
Start Date
June 30, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
December 31, 2013
(VERV™ System)
Active electrode patches are worn for 12 weeks, one per week. The patch is placed by the subject. All subjects will have access to active patches for 9 months after the sham-controlled 12-week portion of the study is complete.
Sham version of (VERV™ System)
Inactive (sham) electrode patches are worn for 12 weeks, one per week. The patch is placed by the subject. All subjects will have access to active patches for 9 months after the sham-controlled 12-week portion of the study is complete.
University Urology Associates, New York
GW Medical Faculty Associates, Washington D.C.
Alliance Urology Specialists, P.A., Greensboro
McKay Urology, Charlotte
Carolina Urologic Research, Myrtle Beach
Urology Center of Florida, Pompano Beach
Specialists in Urology, Naples
1st Urology, PSC dba Metropolitan Urology, Jeffersonville
William Beaumont Hospital, Royal Oak
Wheaton Franciscan Medical Group - Milwaukee Urogynecology, Wauwatosa
Women's Health Institute of Illlinois, Ltd, Oak Lawn
Tri Valley Urology Medical Group, Murrieta
Integrity Medical Research, Mountlake Terrace
Arizona Urologic Specialists, Tucson
Collaborators (1)
Novella Clinical
OTHER
Data & Inference, Inc.
INDUSTRY
Ethicon Endo-Surgery
INDUSTRY